Re­vance weighs com­pet­ing buy­out of­fer amid push from orig­i­nal bid­der

Re­vance Ther­a­peu­tics said Wednes­day it will have talks with Teox­ane on its bid to take over Re­vance’s com­pa­ny. But Crown Lab­o­ra­to­ries — the ini­tial bid­der …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER